Prenetics’ IM8 Brings Lily Collins On Board as Global Ambassador and Shareholder Amid Raised 2026–2027 Guidance
I'm LongbridgeAI, I can summarize articles.Prenetics Group (PRE) announced that actress Lily Collins has joined IM8 as its first Global Ambassador and shareholder. Concurrently, the company raised its full-year 2026 revenue guidance to $220–$230 million and initiated 2027 guidance of at least $400 million. Prenetics also reported positive consolidated adjusted free cash flow from July 2026 onward, alongside a 'Buy' analyst rating with a $36 price target.
The latest update is out from Prenetics Group ( (PRE) ).
Prenetics Global Limited, the parent of premium health and longevity brand IM8, operates in the consumer health sector with a focus on science-backed daily nutrition systems. Co-founded with David Beckham, IM8’s flagship Daily Ultimate Essentials consolidates multiple supplements into one NSF-certified drink, supporting a rapidly expanding global business that now ships over 200,000 servings a day to 46 countries and generates the majority of its revenue outside the U.S.
On August 20, 2026, Prenetics’ IM8 announced a multi-year global partnership with actress and producer Lily Collins, who becomes both IM8’s first film-and-television Global Ambassador and a shareholder in the company. The collaboration deepens IM8’s reach into global culture and a largely female audience, complementing its roster of sports and wellness ambassadors, and arrives as Prenetics lifts full-year 2026 revenue guidance to $220–$230 million, initiates 2027 guidance of at least $400 million, and reports positive consolidated adjusted free cash flow from July 2026 onward.
The most recent analyst rating on (PRE) stock is a Buy
with a $36.00 price target.
To see the full list of analyst forecasts on Prenetics Group stock,
see the PRE Stock Forecast page.
Spark’s Take on PRE Stock
According to Spark, TipRanks’ AI Analyst, PRE is a Neutral.
The score is held back primarily by weak financial performance—persistent losses and continued free cash flow burn—despite improving revenue and gross margins and a low-debt balance sheet. Technicals are moderately supportive with the stock trading above key moving averages, while valuation is constrained by a negative P/E and no dividend yield. The latest earnings call adds upside due to raised guidance and strong subscription-led growth metrics, but elevated marketing-driven losses and reporting/guidance clarity risks temper the outlook.
To see Spark’s full report on PRE stock,
click here.
More about Prenetics Group
Prenetics Global Limited, listed on Nasdaq under the ticker PRE, is a consumer health company focused on advancing human health and longevity. Its flagship brand IM8, co-founded with David Beckham, offers science-backed premium daily nutrition, led by the Daily Ultimate Essentials system that consolidates multiple supplements into a single NSF Certified for Sport daily drink. IM8 has rapidly scaled to an annualized revenue run-rate of about $251 million, ships more than 200,000 servings a day to 46 countries, and targets a global audience through an equity-aligned ambassador roster from elite sports and wellness media.
IM8 positions itself at the top end of the core nutrition market, blending medical, academic and space-science expertise to deliver holistic formulations. The brand emphasizes convenience, clean ingredients and performance validation, aiming to replace traditional pill-heavy supplement regimes with a single, all-in-one powder. Prenetics leverages IM8’s fast growth, international footprint and celebrity partnerships to strengthen its presence in premium health and longevity, while maintaining a focus on cash-flow generation and pipeline expansion, including upcoming hydration and gummies products.
Average Trading Volume: 216,662
Technical Sentiment Signal: Buy
Current Market Cap: $332.6M
For an in-depth examination of PRE stock, go to TipRanks’ Overview page.